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49 years male, who comes to the urology department, complaining of 8 months of lower abdominal pain,
burning and oppressive type, of variable intensity reaching 9/10, which is occasionally exacerbated by
urination, associated with intermittent gross hematuria, dysuria, refers no fever at any time. Patient with
past medical history of bladder and right kidney Tuberculosis (TBC) 25 years ago, treated with a simple
right nephrectomy and bladder augmentation with antrum segment of stomach, for low bladder
capacity. Never showed any symptom during those 25 years lapsing time
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The use of gastric segment for bladder reconstruction, was ﬁrst
described by Sinaiko in dogs and later described in humans by
Leong, however, this was actually widely accepted for clinical use,
after the work presented by Adams in pediatric population.1
Initially, its main indication is limited to patients with renal
failure, metabolic acidosis, or short bowel syndrome. But eventually
the process was gaining ground and started using in neurogenic
cases for urinary diversion and/or neobladder for bladder cancer,
bladder augmentation and management of low capacity bladders
secondary to various diseases such as tuberculosis, reconstruction
of the urinary tract and bladder extroﬁas, posterior urethral valves,
epispadias among others.2Case presentation
49 years male, who comes to the urology department, com-
plaining of 8 months of lower abdominal pain, burning and
oppressive type, of variable intensity reaching 9/10, which isCIMI, Caracas, Miranda 1080,
ail.com, martinﬁdodido@
Inc. This is an open access article uoccasionally exacerbated by urination, associated with intermittent
gross hematuria, dysuria, refers no fever at any time.
Patient with past medical history of bladder and right kidney
Tuberculosis (TBC) 25 years ago, treated with a simple right ne-
phrectomy and bladder augmentation with antrum segment of
stomach, for low bladder capacity. Never showed any symptom
during those 25 years lapsing time.
Hematuria work up is started with renal and urinary tract ul-
trasound which suggests vegetative lesions vs. intravesical polyps,
cystoscopy is performed ﬁnding pseudo-diverticulum in right side
lateral wall behind left upper neck, and a whitish lesion which is
biopsed; no evident tumor lesions. Biopsy showed antrum tissue
with mild chronic atrophic gastritis activity, positive for Heli-
cobacter pylori and negative for metaplasia or dysplasia (Fig. 1).
Patient was treated for Heliycobacter Pilory with three medica-
tions scheme (Clarithromycin 500 mg/TID, Amoxicillin 1 g/BID,
and Omeprazole 40 mg/OD for 10 days) and symptoms were
resolved.Discussion
The use of gastric tissue in the reconstruction of the lower
urinary tract has been controversial since its ﬁrst description
in 1950 and its amendment in 1970; gastric tissue is mainly used
as an alternative to intestinalcystoplasty (colocystoplasty ornder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Bladder biopsy, giemsa coloring, bacillus is observed in light of the gland,
arrowed.
H.A. Aponte et al. / Urology Case Reports 3 (2015) 70e71 71ileocystoplasty) in patients with renal insufﬁciency, in which the
metabolic acidosis is a common ﬁnding, also in short bowel syn-
drome, among others.
The stomach produces few mucus and has adequate compla-
cency. Its mucosa is impermeable to most ions, allowing adequate
net ﬂow of water. In addition, the mucosa allows easy and effective
ureteral reimplantation; reduces rates of urinary tract infection,
possibly by aciduria and decreases the frequency of formation of
bladder stones.2
Nevertheless the disadvantages include peptic ulcer in the
bladder, perforation of the gastric segment, hyponatremic hypo-
chloremic alkalosis, hypergastrinemia, formation of secondary tu-
mors andmaybemore important the hematuria-dysuria syndrome.
Hematuria-dysuria syndrome is characterized by symptoms
such as bladder spasms; suprapubic, penis or periurethral pain,
coffee brown or macroscopic hematuria without urinary infections;
excoriation of the skin, and/or dysuria without infection.3
Using the Nguyen criteria for the diagnosis of hematuria dysuria
syndrome, a wide incidence has been reported; going from 24%,
through 36% to 70% in 78, 57 and 23 children study respectively.
Usando los criterios de Nguyen, se ha reportado una incidencia
amplia del síndrome; desde un 24% en una serie de 78 niños con
seguimiento a 8,1 años, llevados a gastrocistoplastia reportada por
Plaire, pasando por un 36% en 57 niños tratados entre 1989 y 1992;
hasta 70% en un estudio en 23 pacientes con un seguimiento medio
de 45 meses.
Although other authors have reported minor incidence as
DeFoor in 2003, who reported hematuria-dysuria syndrome in 18%
of patients, which were successfully treated in its entirely.
The etiology of the hematuria-dysuria syndrome is not
completely known. The decrease in the pH of the urine was not a
signiﬁcant association, although other authors have reported a
difference between bladder mucosa and urinary pH. However, pa-
tients with irritative urinary symptoms have well responded tohistamine receptors 2 blockers, leaving aciduria as the possible
etiology of the syndrome.3
Some authors have attributed gastrin high levels as a cause of
dysuria hematuria syndrome, although others found no direct
relationship between gastrin levels and irritative symptoms.3
Another possible factor involved in the etiology has been the
Helicobacter pylori, which was diagnosed using ELISA technique,
4 of 10 patients with Helicobacter pylori, since there is no an spe-
ciﬁc standard treatment for intravesical Helicobacter Pylori we
initiate amoxicillin, metronidazole and inhibitor of H2 (ranitidine)
for 2 to 4weeks, with improvement of symptoms, decreased gastrin
levels and normal ELISA control.4
There is no consensus in the management of the hematuria
dysuria syndrome, although some studies reported that 13% of cases,
the symptoms were reported as mild, self-limiting and did not
require additionalmedicalmanagement; 6%patients usedhistamine
2 receptor blockers to controlmild symptoms; 4%were continuously
treated with histamine 2 receptor blockers to control symptoms.
While other authors report that up to 70% of patients require of
histamine 2 receptor blockers and/or hydrogen bomb inhibitors to
control symptoms.5
Multiple approaches have been studied when managing hema-
turia dysuria syndrome. Castellan, in 29 patients, showed that the
empirical use of high doses antimuscarinics for symptoms of he-
maturia dysuria syndrome, had no urodynamic or clinical beneﬁt.6
Conclusions
The most common complication in gastrocystoplasty is
hematuria-dysuria syndrome, symptoms are usually intermittent,
self-limiting and improve with time. Most patients are controlled
with intermittent use of H2 blockers.
The etiology is believed to be the production of hydrochloric
acid by the gastric segment and reduced by the damping effect of
urine. However, the symptoms have been seen even with urine
acidity in the normal range. An alternative explanation is by Heli-
cobacter pylori, which when treated symptoms are resolved.
Conﬂicts of interest
The authors declare they have no conﬂicts of interest.
References
1. Singla AK. Surgery: Outcomes of gastric-segment bladder reconstruction. Nat Rev
Urol. 2012;9(7):362e363.
2. Biers SM, Venn SN, Greenwell TJ. The past, present and future of augmentation
cystoplasty. BJU Int. 2012;109(9):1280e1293.
3. Chadwick Plaire J, Snodgrass WT, Grady RW, Mitchell ME. Long-term followup of
the hematuria-dysuria syndrome. J Urol. 2000;164(3 Pt 2):921e923.
4. Celayir S, Goksel S, Buyukunal SN. The relationship between Helicobacter pylori
infection and acid-hematuria syndrome in pediatric patients with gastric
augmentation-II. J Pediatr Surg. 1999;34(4):532e535.
5. Leonard MP, Dharamsi N, Williot PE. Outcome of gastrocystoplasty in tertiary
pediatric urology practice. J Urol. 2000;164(3 Pt 2):947e950.
6. Castellan M, Gosalbez R, Bar-Yosef Y, Labbie A. Complications after use of gastric
segments for lower urinary tract reconstruction. J Urol. 2012;187(5):1823e1827.
